Nearly one million bottles of two commonly prescribed medications used to treat chronic heart failure and complications related to chronic kidney disease have been voluntarily recalled after an unexpected foreign substance was discovered on some tablets.
The recall was initiated by Amgen and affects approximately 944,000 bottles of the medications after foreign material was identified on the outer coating of tablets during routine quality testing. The contamination appears to have been isolated to a packaging area within one manufacturing facility, and officials say the overall risk to patients remains low. No injuries or adverse events related to the issue have been reported.
For the full story, please visit blackdoctor.com







